End-of-day quote
Taiwan S.E.
03:30:00 26/06/2024 am IST
|
5-day change
|
1st Jan Change
|
42.2
TWD
|
-0.47%
|
|
+0.84%
|
-4.31%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
5,436
|
6,873
|
7,227
|
5,661
|
4,218
|
5,830
|
Enterprise Value (EV)
1 |
6,063
|
8,545
|
8,684
|
7,081
|
5,650
|
7,194
|
P/E ratio
|
14
x
|
64.6
x
|
20.3
x
|
18.9
x
|
28.6
x
|
-41.6
x
|
Yield
|
3.4%
|
0.94%
|
2.71%
|
2.76%
|
1.87%
|
0.68%
|
Capitalization / Revenue
|
2.4
x
|
3.9
x
|
3.59
x
|
2.37
x
|
2.23
x
|
3.66
x
|
EV / Revenue
|
2.67
x
|
4.85
x
|
4.31
x
|
2.96
x
|
2.99
x
|
4.52
x
|
EV / EBITDA
|
8.03
x
|
19.8
x
|
12.1
x
|
9.6
x
|
12.1
x
|
31.7
x
|
EV / FCF
|
-33.2
x
|
-12.5
x
|
72.4
x
|
43.3
x
|
-135
x
|
48.9
x
|
FCF Yield
|
-3.01%
|
-7.97%
|
1.38%
|
2.31%
|
-0.74%
|
2.04%
|
Price to Book
|
2.17
x
|
2.8
x
|
2.6
x
|
1.95
x
|
1.4
x
|
2.08
x
|
Nbr of stocks (in thousands)
|
1,29,420
|
1,29,678
|
1,30,681
|
1,30,893
|
1,31,799
|
1,32,205
|
Reference price
2 |
42.00
|
53.00
|
55.30
|
43.25
|
32.00
|
44.10
|
Announcement Date
|
14/03/19
|
12/03/20
|
10/03/21
|
11/03/22
|
10/03/23
|
08/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
2,269
|
1,760
|
2,014
|
2,391
|
1,889
|
1,593
|
EBITDA
1 |
755
|
430.8
|
718.8
|
737.8
|
465.3
|
227.2
|
EBIT
1 |
475.5
|
150.4
|
417.3
|
390.6
|
137.5
|
-126.1
|
Operating Margin
|
20.96%
|
8.54%
|
20.72%
|
16.33%
|
7.28%
|
-7.92%
|
Earnings before Tax (EBT)
1 |
494.8
|
136.8
|
388.9
|
374.9
|
129.1
|
-141.6
|
Net income
1 |
394.9
|
106.7
|
359
|
303.3
|
148.8
|
-139.3
|
Net margin
|
17.41%
|
6.06%
|
17.83%
|
12.68%
|
7.87%
|
-8.74%
|
EPS
2 |
2.990
|
0.8200
|
2.730
|
2.290
|
1.120
|
-1.060
|
Free Cash Flow
1 |
-182.8
|
-681.4
|
119.9
|
163.6
|
-41.7
|
147
|
FCF margin
|
-8.06%
|
-38.7%
|
5.95%
|
6.84%
|
-2.21%
|
9.23%
|
FCF Conversion (EBITDA)
|
-
|
-
|
16.68%
|
22.18%
|
-
|
64.71%
|
FCF Conversion (Net income)
|
-
|
-
|
33.4%
|
53.95%
|
-
|
-
|
Dividend per Share
2 |
1.429
|
0.5000
|
1.500
|
1.193
|
0.5999
|
0.3000
|
Announcement Date
|
14/03/19
|
12/03/20
|
10/03/21
|
11/03/22
|
10/03/23
|
08/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
628
|
1,672
|
1,457
|
1,420
|
1,432
|
1,364
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.8312
x
|
3.882
x
|
2.027
x
|
1.924
x
|
3.078
x
|
6.002
x
|
Free Cash Flow
1 |
-183
|
-681
|
120
|
164
|
-41.7
|
147
|
ROE (net income / shareholders' equity)
|
15.8%
|
3.74%
|
13.4%
|
10.4%
|
4.59%
|
-5.24%
|
ROA (Net income/ Total Assets)
|
7.78%
|
2.12%
|
5.29%
|
4.68%
|
1.63%
|
-1.57%
|
Assets
1 |
5,075
|
5,020
|
6,793
|
6,479
|
9,137
|
8,879
|
Book Value Per Share
2 |
19.30
|
18.90
|
21.30
|
22.20
|
22.80
|
21.20
|
Cash Flow per Share
2 |
2.610
|
3.070
|
3.140
|
3.610
|
3.450
|
2.770
|
Capex
1 |
731
|
1,031
|
423
|
357
|
361
|
182
|
Capex / Sales
|
32.21%
|
58.58%
|
20.99%
|
14.92%
|
19.13%
|
11.41%
|
Announcement Date
|
14/03/19
|
12/03/20
|
10/03/21
|
11/03/22
|
10/03/23
|
08/03/24
|
|
1st Jan change
|
Capi.
|
---|
| -4.31% | 172M | | +2.94% | 103B | | -11.86% | 59.25B | | +72.86% | 47.15B | | +11.16% | 37.09B | | +0.43% | 31.09B | | +4.42% | 18.82B | | +14.69% | 16.97B | | +9.34% | 13.67B | | -3.67% | 12.77B |
Other Commodity Chemicals
|